Reversing Development of Alzheimer’s Disease and Dementia Using Unique Hyperbaric Oxygen Therapy Protocol

Elevated Blood Flow and Improved Oxygenation in Brain

Revealed: The Secrets our Clients Used to Earn $3 Billion

Study results program raised blood circulation and enhanced oxygenation in the brain of clients struggling with cognitive problems. Credit: Tel Aviv University

Reversal of the biological trademarks accountable for advancement of Alzheimer’s illness and dementia utilizing distinct hyperbaric oxygen treatment procedure.

A group of detectives from Tel Aviv University has actually been successful in bring back brain injury by hyperbaric oxygen treatment (HBOT). This is the very first time in the clinical world that non-drug treatment has actually been shown reliable in avoiding the core biological procedures accountable for the advancement of Alzheimer’s illness. Using a particular procedure of hyperbaric oxygen treatment (HBOT), cerebral blood circulation (CBF) improved/increased in senior clients by 16-23%, reducing vascular dysfunction and amyloid problem.

The research study, part of an extensive research study program directed towards aging and accompanying conditions as a reversible illness, holds pledge for a brand-new tactical method to the avoidance of Alzheimer’s by attending to not just the signs or targeting biomarkers, however rather the core pathology and biology accountable for the advancement of the illness.

Uri Ashery

Prof UriAshery Credit: Tel Aviv University

The research study was carried out under the management of a group of detectives from Tel Aviv University:Prof Shai Efrati,Prof Uri Ashery,Dr Ronit Shapira,Dr Pablo Blinder, andDr AmirHadanny They are members of the Sagol School of Neuroscience, the George S. Wise Faculty of Life Sciences, and the Sackler Faculty of Medicine at Tel Aviv University in addition to from the Shamir MedicalCenter The findings of the development research study were released in the appreciated journal Aging

Shai Efrati

Prof ShaiEfrati Credit: Tel Aviv University

Hyperbaric medication is a kind of treatment that needs clients to be kept in unique chambers in which the air pressure is much greater than that generally experienced at sea level. In addition, they breathe air made up of 100% oxygen. Hyperbaric medication is thought about safe and currently serves to deal with a substantial list of medical conditions– likewise here inIsrael In current years, clinical proof has actually suggested that distinct procedures of hyperbaric treatment can causing repair work of damage brain tissue and restored development of capillary and afferent neuron in the brain.

The very first phase of the research study was performed on an animal design, in the course of which it was shown conclusively through evaluation of brain tissues that a particular healing procedure produces an enhancement in vascular function and the production of new members vessels. It likewise avoids the deposit of brand-new amyloid plaques on the brain cells and even causes the elimination of existing amyloid plaque deposits. Amyloids are non-soluble proteins. Deposits of such proteins in the brain are gotten in touch with extreme degenerative conditions such as Alzheimer’s illness.

Pablo Blinder

Dr PabloBlinder Credit: Tel Aviv University

At the next phase, the results of the treatment were analyzed for individuals above the age of 65 with cognitive decrease, with a focus on amnesia– a phase preceding Alzheimer andDementia The treatment consisted of a series of 60 session of HBOT distinct in pressure chambers over a duration of 90 days. The results on the brain were assessed by high resolution perfusion MRI. The hyperbaric treatment procedure generated: increased blood circulation in the series of 16%-23%; considerable enhanced in memory by 16.5% usually, considerable enhancement in attention and info processing speed.

Prof Uri Ashery discusses, “By studying and treating Alzheimer’s disease in the animal model, we can implement our findings to include humans as well. After a series of hyperbaric treatments, elderly patients who were already suffering from memory loss showed an improvement of blood flow to the brain — as well as a real improvement in cognitive performance. Consequently, we succeeded in demonstrating the latent potential of hyperbaric medicine for treatment of neurologic conditions that originate from hypoxia — that is to say, a deficiency of oxygen reaching the cells.”

Dr Pablo Blinder states, “This breakthrough was enabled thanks to a new research approach that employs multi-photon microscopes. This allowed us to follow up improvements in indices taken from animal models before and after each chamber treatment. At the same time, we check blood vessel diameters and the formation of amyloid plaques in their brains.”

Ronit Shapira

Dr RonitShapira Credit: Tel Aviv University

Dr Ronit Shapira includes, “The combination of an animal model from which we could learn the pathology of the disease, together with existing and available therapy, raises the hope that we will now be able to fight one of the greatest challenges to the western world. According to our findings, hyperbaric therapy given at a young age is likely to prevent this severe disease entirely.”

Prof Shai Efrati summarize the group’s findings, “By treating the root problem that causes cognitive deterioration with age, we are in fact mapping out the way to prevention. It is likely that hyperbaric medicine can potentially provide the opportunity for living with good brain function without relating to chronological age. The idea is to commence therapy before the onset of clinical symptoms of Dementia and before deterioration and loss of extensive brain tissue. This is the stage at which blood vessels become occluded and the blood flow and the oxygen supply to the brain are diminished — a phenomenon that can already take place at a relatively early age.”

Reference: “Hyperbaric oxygen therapy alleviates vascular dysfunction and amyloid burden in an Alzheimer’s disease mouse model and in elderly patients” by Ronit Shapira, Amos Gdalyahu, Irit Gottfried, Efrat Sasson, Amir Hadanny, Shai Efrati, Pablo Blinder and Uri Ashery, 9 September 2021, Aging
DOI: 10.18632/ aging.203485

This site uses Akismet to reduce spam. Learn how your comment data is processed.